Mesoblast Ltd. Files 6-K Report
Ticker: MESO · Form: 6-K · Filed: Apr 29, 2026 · CIK: 0001345099
| Field | Detail |
|---|---|
| Company | Mesoblast Ltd (MESO) |
| Form Type | 6-K |
| Filed Date | Apr 29, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, foreign-issuer, corporate-update
TL;DR
MESO files 6-K, likely with news. Check EX-99.1.
AI Summary
On April 29, 2026, Mesoblast Ltd. filed a Form 6-K, reporting on its activities. The filing includes an exhibit (EX-99.1) which appears to be a press release or similar announcement, along with associated graphic files.
Why It Matters
This filing provides an update on Mesoblast Ltd.'s corporate activities, which could contain important information for investors regarding the company's progress or announcements.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) and does not inherently indicate significant new risks.
Key Numbers
- 2026-04-29 — Period of Report (Date the report covers)
- 2026-04-28 — Filing Date (Date the report was accepted by the SEC)
Key Players & Entities
- MESOBLAST LTD (company) — Filer of the 6-K report
- 0001345099 (company) — CIK number for MESOBLAST LTD
- EX-99.1 (document) — Exhibit attached to the 6-K filing
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign issuer which the securities laws of the United States require to be filed with the SEC if the issuer publishes, or is required to publish, any information that is important to investors.
What is the accession number for this filing?
The SEC Accession No. for this filing is 0001345099-26-000051.
What is the CIK number for Mesoblast Ltd.?
The CIK number for Mesoblast Ltd. is 0001345099.
What is the SIC code listed for Mesoblast Ltd.?
The SIC code listed is 2836, which corresponds to Biological Products, (No Diagnostic Substances).
What is included as an exhibit in this filing?
Exhibit EX-99.1 is included, along with associated graphic files.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 29, 2026 regarding MESOBLAST LTD (MESO).